Daiichi Sankyo Terminates $650 Million Deal With This U.S. Pharma Post author:Sam Post published:August 30, 2017 Post category:BioPharma August 31, 2017By Alex Keown, BioSpace.com Breaking News Staff… Source: BioSpace You Might Also Like Motif Bio Explodes After Phase III Clinical Trial Success October 3, 2017 Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target October 8, 2017 Mettler-Toledo To Exhibit At July 30, 2017
